BUSCADOR DE PRODUCTOS

Filtra tu búsqueda por las siguientes categorias.

PROVEEDOR
CATEGORÍA
REACTIVIDAD


RESULTADOS DE BÚSQUEDA

mostrando 50 de 603 resultados
Referencia Nombre Unidad Proveedor Aplicacion Clonalidad Huésped Reactividad Precio
Stm130Sur-01 1. Gastroesophageal junctional carcinoma, 65 cases. 2. Survival information available, being followed up for 3.5-7 years. 1.5mm USBiolab € 840,00
LugA150Sur-01 1. Lung adenocarcinoma (75 cases), tumor (1 core/dase) and matched normal adjacent tissue (1 core/case). 2. Survival information available. Being followed up for more than 5 years. 3. With IHC data of VEGF and survivin. 1.5mm USBiolab € 985,00
MorgH090-01 1. Multiple organ (29 types) from aborted fetus (5 cases). 1-5 cases/organ, 1 core/case. 2. Esophagus, stomach, duodenum, jejunum, ileum, liver, pancreas, lung, heart, aorta, ovary, testis, adrenal, kidney, bladder, ureter, pituitary, cerebrum, hippocam 2.0mm USBiolab € 503,00
Eso127-01 1. Esophagus squamous cell carcinoma (50 cases), 27 cases have tumor(1 core/case) and matched normal adjacent tissue (1 core/case) and negative/positive lymph node (1 core/case), 23 cases have tumor tissue (1 core/case) and positive lymph node (1 core/cas 1.5mm USBiolab € 400,00
Liv01-002 1. Liver carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other tumor tissue (20 cases), 1 core/case. 2. Pathology grade 1, 2, 3. 1.0mm USBiolab € 255,00
Kid02-003 1. Kidney clear cell carcinoma (32 cases), 1 core/case. 2. Pathology grade 2-3, 3. 2.0mm USBiolab € 156,00
Lug02-003 1. Lung squamous cell carcinoma (32 cases), 1 core/case. 2. Pathology grade 2-3, 3. 2.0mm USBiolab € 156,00
Liv02-003 1. Hepatocellular carcinoma (32 cases), 1 core/case. 2. Pathology grade 2-3, 3. 2.0mm USBiolab € 156,00
Pan180Sur-01 1. Pancreatic adenocarcinoma (90 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Clinical stage I, II, IV (Version 7.0). 2. Survival information available. Being followed up for 3-7 years. 3. Smoking history, drinking histo 1.5mm USBiolab € 1.571,00
Liv01-008 1. Hepatocellular carcinoma (100 cases, pathology grade I, II, III). 2. Sclerosing hepatocellular carcinoma (5 cases) 3. Liver cirrhosis (20 cases) 4. 3 cores/case. 1.0mm USBiolab € 372,00
Eso4-007 1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case. 2. Pathology grade 1, 1-2, 2, 2-3, 3. 2.0mm USBiolab € 241,00
Rau120Sur-01 1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case 2. Survival information available. Being followed up for 0.5-7 years. 1.5mm USBiolab € 840,00
Rec02-002 1. Rectum adenocarcinoma (32 cases), 1 core/case. 2. Pathology grade 2. 2.0mm USBiolab € 156,00
Eso03-003 1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases), adenocarcinoma (5 cases), small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases). Gastric carcinoma (2 cases 2.0mm USBiolab € 241,00
ColM060CS-01 30 cases of mucous adenocarcinoma of colon /normal adjacent tissue, 1 core/case.Clinical stage I-IV. 2.0mm USBiolab € 286,00
Stm150CS-01 1. Early stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case. 2. Clinical Stage I. 29 cases of T1N0M0, 5 cass of T1N1M0, 41 cases of T2N0M0. 1.5mm USBiolab € 695,00
Liv04-001 1. Hepatocellular carcinoma (41 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Pathology grade 1, 2, 3. 3. Paired frozen samples accessible. 2.0mm USBiolab € 283,00
Stm150CS-02 1. stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case. 2. 15 cases of clinical Stage I . 25 cases of stage II, 25 cass of stage III, 10 cases of stage IV.(all cases overlapped with Stm180-01) 1.5mm USBiolab € 476,00
Bre01-003 1. Breast carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other carcinoma (20 cases), 1 core/case. 2. Pathology grade 1, 2, 3. 3. ER, PR information. 1.0mm USBiolab € 325,00
Rec180Sur-04 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue. Clinical stage I-IV (Version 7.0). 2. Surgery date 2007.10 - 2008.10, visit date 2012.8. Being followed up for 5-6 years. 1.5mm USBiolab € 1.130,00
Stm02-004 1. Signet ring cell carcinoma (32 cases), 1 core/case. 2. Pathology grade 3. 2.0mm USBiolab € 156,00
DS147-01 1. Colon adenocarcinoma (24 cases) and rectum adenocarcinoma (25 cases), tumor (1 core/case), matched normal adjacent tissue (1 core/case) and lymph nodes (1 core/case). 2. Clinical Stage N0 (12 cases), N1a (5 cases), N1b (5 cases), N2a (9 cases), N2b ( 1.5mm USBiolab € 428,00
DS075-01 1. Carcinoma of large intestine, 14 cases have primary tissue, normal adjacent tissue and metastasis tissue, 14 cases have primary tissue and metastasis tissue, 4 cases have metstasis tissue. 2.0mm USBiolab € 400,00
Rec180Sur-05 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue. 2. Clinical stage I-IV (Version 7.0). 3. Surgery date 2008.12?2009.12, visit date 2014.3. Being followed up for 4.3-5.3 years. 1.5mm USBiolab € 1.168,00
Lug150PT-01 1. Non-small cell lung carcinoma (75 cases), containing adenocarcinoma (30 cases), squamous cell carcinoma (30 cases), bronchio alveolar carcinoma (5 cases), adenosquamous carcinoma (7 cases) and large cell carcinoma (3 cases). 2. Tumor (1 core/case) an 1.5mm USBiolab € 400,00
Col060CS-01 1. Early colon adenocarcinoma, 30 cases. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Wih clinical stage information (Version 7.0). 1.5mm USBiolab € 283,00
Col180-01 1. Colon adenocarcinoma (90 cases), tumor and NAT. 2. 100% cases have TNM detail information. Clinical stage I-IV (Version7.0). 3. Pathology grade 1, 2, 3. 1.5mm USBiolab € 545,00
Pro180-02 1. Prostate carcinoma(97 cases), 78 cases have tumor (1 core/case) and normal adjacent tissue (1 core/case). 19 cases have tumor (1 core/case). 5 cases have normal tissue. 2. Pathology grade and Gleason grade available. 1.5mm USBiolab € 695,00
Stm030PT-01 Various gastric diseaases, 1 core/case:normal gastric mucosa, gastric ulcer, gastric polyps and gastric intraepithelial neoplasia, gastric carcinoma/normal adjacent tissue 2.0mm USBiolab € 219,00
Col180Sur-03 1. Colon adenocarcinoma (90 cases) with survival information, tumor (1 core/case) and matched normal adjacent tissue (1 core/case) 2. Clinical stage I-IV (Version7.0). 3. Surgery date 2008.4-2008.11, visit date 2012.8. Being followed up for 4.8-5.4 years 1.5mm USBiolab € 1.130,00
Kid060CS-01 1.25 cases Renal clear cell carcinoma, tumor with matched normal adjacent tissue (or remote tissue/NAT/tumor) 2.Clinical stage(AJCC 7.0)I II III IV 3.5 cases of kidney cancer metastases 2.0mm USBiolab € 286,00
Eso150-01 1. Esophagus squamous cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Clinical stage I (11 cases), II (27 cases), III (27 cases), IV (10 cases). 3. 100% cases have TNM detail information. 4. Patho 1.5mm USBiolab € 545,00
Col180Sur-02 1. Colon adenocarcinoma (93 cases) with survival information, 87 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case), 6 cases have tumor tissue (1 core/case). 2. Clinical stage I-IV (Version7.0). 3. Surgery date 2007.5-2008.4 1.5mm USBiolab € 1.280,00
Kid01-004 1. Kidney clear cell carcinoma (62 cases). 2. Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case). 1.0mm USBiolab € 325,00
Liv030PG-01 1. Hepatocellular carcinoma (15 cases), tumor (1 cores/case) and matched normal adjacent tissue (1 cores/case). 2. Pathology grade 1, 2, 3. 2.0mm USBiolab € 156,00
Liv180Sur-03 1. Hepatocellular carcinoma (90 cases). Tumor (1 core/case) and NAT (1 core/case). 2. Survival Information available. 3. Surgery date 2010.1-2011.9. Visit date 2013.9. Being followed up for 2-3.7 years. 1.5mm USBiolab € 1.280,00
LivT10-205 1. Liver disease (20 cases), containing hepatocellular carcinoma (9 cases), cholangiocellular carcinoma (2 cases), hepatic adenoma (1 case), cirrhosis (3 cases) and hepatic hemangioma (5 cases). 2. Biochemical indicator available (AFP,HBV,HCV RNA). 2.0mm USBiolab € 241,00
Stm180Sur-02 1. Gastric adenocarcinoma (90 cases) with survival information. 2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 3. Clinical stage I-IV (Version 7.0). 4. Being followed up for 5-5.5 years. VEGF and survivin information availab 1.5mm USBiolab € 1.133,00
Gal100-01 1. Gallbladder carcinoma, 80 cases. 2. 20 cases have tumor and normal adjacent tissue. 60 cases have only tumor. 3. Survival information available. 1.5mm USBiolab € 545,00
Pro162-02 1. Prostate cancer, intraepithelial neoplasia, normal gland, 80 cases, 2 cores/case. 2. Pre-operationi PSA, Gleason Score, ECT, capsular invasion information available. 1.5mm USBiolab € 695,00
Stm01-007 1. Gastric carcinoma (110 cases), containing gastric carcinoma (83 cases) and esophagogastric junction carcinoma (27 cases). 2. Normal adjacent tissue (20 cases), containing adjacent normal mucosa tissue (10 cases), chronic gastritis (10 cases). 3 cores/ 1.0mm USBiolab € 475,00
MorgF090-01 1. Multiple organ (24 types) normal tissue array. 2-6 cases /organ, 1 core /case. 2. Thyroid, tongue, esophagus, stomach, duodenum, jejunum, ileum, appendix, colon, rectum, liver, pancreas, trachea, lung, myocardial, artery, skeletal muscle, skin, prost 2.0mm USBiolab € 503,00
Stm02-001 1. Gastric adenocarcinoma (32 casee), 1 core/case. 2. Pathology grade 1, 1-2 2.0mm USBiolab € 156,00
LugA030PG-01 1. Lung adenocarcinoma (15 cases), Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Pathology grade 2,3. 2.0mm USBiolab € 197,00
Eso01-004 1. Esophagus squamous cell carcinoma (92 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Clinical stage I-IV (Version 7.0). 3. 60% cases have TNM detail information. 4. Pathology grade 1, 2, 3. 1.5mm USBiolab € 475,00
Kid03-002 1. Kidney clear cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 2. Pathology grade 1. 2.0mm USBiolab € 241,00
Col180Sur-07 1. Colon adenocarcinoma (90 cases) with survival information, tumor(1 core/case) and matched normal adjacent tissue (1 core/case). 2. Clinical stage I-IV (Version7.0). 3. Surgery date 2009.1-2009.10, visit date 2014.5. Being followed up for 4.6-5.3 yea 1.5mm USBiolab € 1.207,00
Bre140Sur-02 1. Breast cancer 140 cases. 1 core/case. 2. Clinical Stage I, II, III (Version 6.0). 3. Surgery date 2004.8?2008.12, visit date 2014.7 . Being followed up for 5.6~10 years. 4. 140 cases overlaped with Bre150Sur-02 1.5mm USBiolab € 1.243,00
Liv02-001 1. Hepatocellular carcinoma (32 cases), 1 core/case. 2. Pathology grade 1, 1-2. 2.0mm USBiolab € 156,00
Bre060-01 1. Breast carcinoma (30 cases), mainly invasive ductal carcinoma. 2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). 3. Clinical stage 0, I, II, III (Version 6.0). 4. 100% cases have TNM detail information. 5. Pathology grade 1, 2.0mm USBiolab € 255,00